Ataxia with loss of Purkinje cells in a mouse model for Refsum disease
- PMID: 19004801
- PMCID: PMC2584743
- DOI: 10.1073/pnas.0806066105
Ataxia with loss of Purkinje cells in a mouse model for Refsum disease
Abstract
Refsum disease is caused by a deficiency of phytanoyl-CoA hydroxylase (PHYH), the first enzyme of the peroxisomal alpha-oxidation system, resulting in the accumulation of the branched-chain fatty acid phytanic acid. The main clinical symptoms are polyneuropathy, cerebellar ataxia, and retinitis pigmentosa. To study the pathogenesis of Refsum disease, we generated and characterized a Phyh knockout mouse. We studied the pathological effects of phytanic acid accumulation in Phyh(-/-) mice fed a diet supplemented with phytol, the precursor of phytanic acid. Phytanic acid accumulation caused a reduction in body weight, hepatic steatosis, and testicular atrophy with loss of spermatogonia. Phenotype assessment using the SHIRPA protocol and subsequent automated gait analysis using the CatWalk system revealed unsteady gait with strongly reduced paw print area for both fore- and hindpaws and reduced base of support for the hindpaws. Histochemical analyses in the CNS showed astrocytosis and up-regulation of calcium-binding proteins. In addition, a loss of Purkinje cells in the cerebellum was observed. No demyelination was present in the CNS. Motor nerve conduction velocity measurements revealed a peripheral neuropathy. Our results show that, in the mouse, high phytanic acid levels cause a peripheral neuropathy and ataxia with loss of Purkinje cells. These findings provide important insights in the pathophysiology of Refsum disease.
Conflict of interest statement
The authors declare no conflict of interest.
Figures






References
-
- Wanders RJA, Jakobs C, Skjeldal OH. In: The Molecular and Metabolic Bases of Disease. Scriver CR, Beaudet AL., Sly WS, Valle D, editors. New York: McGraw–Hill; 2001. pp. 3303–3321.
-
- Jansen GA, Waterham HR, Wanders RJ. Molecular basis of Refsum disease: Sequence variations in phytanoyl-CoA hydroxylase (PHYH) and the PTS2 receptor (PEX7) Hum Mutat. 2004;23:209–218. - PubMed
-
- Wierzbicki AS, et al. Refsum's disease: A peroxisomal disorder affecting phytanic acid alpha-oxidation. J Neurochem. 2002;80:727–735. - PubMed
-
- Eldjarn L, et al. Dietary effects on serum-phytanic-acid levels and on clinical manifestations in heredopathia atactica polyneuritiformis. Lancet. 1966;287:691–693. - PubMed
-
- Gibberd FB, Billimoria JD, Page NG, Retsas S. Heredopathia atactica polyneuritiformis (Refsum's disease) treated by diet and plasma-exchange. Lancet. 1979;313:575–578. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources